Copyright © 2012 Seyed Asghar Havaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Global concerns have been raised due to upward trend of Vancomycin Intermediate Staphylococcus aureus (VISA) and Vancomycin Resistant Staphylococcus aureus (VRSA) reports which mean casting doubt on the absolute effectiveness of the last line of antibiotic treatment for S. aureus, vancomycin. Hence, epidemiological evaluation can improve global health care policies. Methodology. 171 Isolates of Staphylococcus aureus were collected from different types of clinical samples in ...
Background: Staphylococcus aureus (s. aureus) nasal carriers, particularly the healthcare staff can ...
Background: Nosocomial infections present a major threat because of the increased prevalence of clin...
Background: Vancomycin has been widely used in the treatment of infections caused by methicillin-res...
Background: Vancomycin has been widely used in the treatment of infections caused by methicillin-res...
Emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant S. aureus...
Background & Aims: Staphylococcus aureus is one of the most common pathogens in nosocomial infection...
Background and Objective: Vancomycin is frequently the antibiotic of choice for the treatment of inf...
Staphylococcus aureus as an opportunistic bacterial pathogen with intrinsic and acquired resistance ...
Authors ’ contribution This work was carried out in collaboration between all authors. Author AF des...
Aims & Objectives: The aim of this study is to evaluate genetic relatedness, antibiotic resistance p...
INTRODUCTION: MRSA is one of the most important etiology of community and hospital acquired infecti...
Background and Aims: Staphylococcus aureus is the most common and important nosocomial pathogens and...
BACKGROUND: Vancomycinresistant Staphylococcus aureus (VRSA) is a serious public health challenging ...
Objective: Vancomycin has been used worldwide due to empirical therapy against methicillin-resistant...
Spread of methicillin-resistant Staphylococcus aureus (MRSA) isolates is a worldwide problem. Molecu...
Background: Staphylococcus aureus (s. aureus) nasal carriers, particularly the healthcare staff can ...
Background: Nosocomial infections present a major threat because of the increased prevalence of clin...
Background: Vancomycin has been widely used in the treatment of infections caused by methicillin-res...
Background: Vancomycin has been widely used in the treatment of infections caused by methicillin-res...
Emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant S. aureus...
Background & Aims: Staphylococcus aureus is one of the most common pathogens in nosocomial infection...
Background and Objective: Vancomycin is frequently the antibiotic of choice for the treatment of inf...
Staphylococcus aureus as an opportunistic bacterial pathogen with intrinsic and acquired resistance ...
Authors ’ contribution This work was carried out in collaboration between all authors. Author AF des...
Aims & Objectives: The aim of this study is to evaluate genetic relatedness, antibiotic resistance p...
INTRODUCTION: MRSA is one of the most important etiology of community and hospital acquired infecti...
Background and Aims: Staphylococcus aureus is the most common and important nosocomial pathogens and...
BACKGROUND: Vancomycinresistant Staphylococcus aureus (VRSA) is a serious public health challenging ...
Objective: Vancomycin has been used worldwide due to empirical therapy against methicillin-resistant...
Spread of methicillin-resistant Staphylococcus aureus (MRSA) isolates is a worldwide problem. Molecu...
Background: Staphylococcus aureus (s. aureus) nasal carriers, particularly the healthcare staff can ...
Background: Nosocomial infections present a major threat because of the increased prevalence of clin...
Background: Vancomycin has been widely used in the treatment of infections caused by methicillin-res...